Kyntra Bio, Inc. (KYNB)
8.50
-0.03
(-0.35%)
USD |
NASDAQ |
Sep 03, 16:00
8.50
0.00 (0.00%)
After-Hours: 20:00
Kyntra Bio Cash from Investing (Quarterly) : 17.67M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.67M |
| March 31, 2026 | 3.018M |
| December 31, 2025 | -51.71M |
| September 30, 2025 | 87.16M |
| June 30, 2025 | -0.013M |
| March 31, 2025 | -0.016M |
| December 31, 2024 | 1.723M |
| September 30, 2024 | 0.755M |
| June 30, 2024 | 72.24M |
| March 31, 2024 | 51.28M |
| December 31, 2023 | 10.24M |
| September 30, 2023 | 54.22M |
| June 30, 2023 | -14.28M |
| March 31, 2023 | 103.48M |
| December 31, 2022 | 1.093M |
| September 30, 2022 | 44.78M |
| June 30, 2022 | 17.30M |
| March 31, 2022 | 25.94M |
| December 31, 2021 | -50.57M |
| September 30, 2021 | -122.15M |
| June 30, 2021 | -57.53M |
| March 31, 2021 | -196.72M |
| December 31, 2020 | 143.77M |
| September 30, 2020 | 98.86M |
| June 30, 2020 | 153.86M |
| Date | Value |
|---|---|
| March 31, 2020 | 56.01M |
| December 31, 2019 | -25.03M |
| September 30, 2019 | 152.77M |
| June 30, 2019 | 18.77M |
| March 31, 2019 | -26.49M |
| December 31, 2018 | -462.86M |
| September 30, 2018 | -89.20M |
| June 30, 2018 | 14.64M |
| March 31, 2018 | 15.30M |
| December 31, 2017 | 20.00M |
| September 30, 2017 | 9.541M |
| June 30, 2017 | 16.92M |
| March 31, 2017 | 23.41M |
| December 31, 2016 | -9.115M |
| September 30, 2016 | 8.585M |
| June 30, 2016 | 2.093M |
| March 31, 2016 | 5.059M |
| December 31, 2015 | -20.17M |
| September 30, 2015 | 8.258M |
| June 30, 2015 | 1.494M |
| March 31, 2015 | 4.552M |
| December 31, 2014 | -140.29M |
| September 30, 2014 | 3.41M |
| June 30, 2014 | 17.38M |
| March 31, 2014 | 12.22M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vericel Corp. | -2.82M |
| Capricor Therapeutics, Inc. | -48.76M |
| ARS Pharmaceuticals, Inc. | 41.57M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.991M |
| Cash from Financing (Quarterly) | -0.005M |
| Free Cash Flow | -38.06M |
| Free Cash Flow Per Share (Quarterly) | -0.9859 |
| Free Cash Flow to Equity (Quarterly) | 15.26M |
| Free Cash Flow to Firm (Quarterly) | -1.623M |
| Free Cash Flow Yield | -110.7% |